ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Shattuck Labs Inc

Shattuck Labs Inc (STTK)

1.055
-0.085
(-7.46%)
Closed March 29 4:00PM
1.05
-0.005
(-0.47%)
After Hours: 7:59PM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.000.100.000.000.000.00 %00-
5.000.000.400.000.000.000.00 %00-

Professional-Grade Tools, for Individual Investors.

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.501.001.801.401.400.000.00 %03-
5.003.604.300.003.950.000.00 %00-

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PRTGPortage Biotech Inc
$ 9.60
(103.82%)
29.92M
LXRXLexicon Pharmaceuticals Inc
$ 0.5741
(65.16%)
405.3M
DBVTDBV Technologies SA
$ 6.12
(56.52%)
21.8M
MYSZMy Size Inc
$ 1.79
(42.06%)
11.89M
LXEHLixiang Education Holding Company Ltd
$ 17.70
(32.78%)
217.53k
STSSSharps Technology Inc
$ 0.0421
(-72.43%)
214.43M
MISTMilestone Pharmaceuticals Inc
$ 0.88
(-60.89%)
33.47M
XTIAXTI Aerospace Inc
$ 1.23
(-50.00%)
1.82M
LGMKLogicMark Inc
$ 0.0258
(-49.41%)
161.36M
ICONIcon Energy Corporation
$ 0.0516
(-48.40%)
27.6M
LXRXLexicon Pharmaceuticals Inc
$ 0.5741
(65.16%)
405.3M
DMNDamon Inc
$ 0.0346
(-22.42%)
314.35M
NVDANVIDIA Corporation
$ 109.67
(-1.58%)
229.88M
STSSSharps Technology Inc
$ 0.0421
(-72.43%)
214.43M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.845
(-7.30%)
200.21M

STTK Discussion

View Posts
TrendTrade2016 TrendTrade2016 1 month ago
STTK HERE COMES 2.00
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
STTK...2.40 MAGNET.....NO...DO WE DARE
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
STTK...MINI MONSTER GETTING LOTS OF LOVE
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
STTK...HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
STTK BUILDING MOMO
👍️0
PonkenPlonken PonkenPlonken 1 month ago
(STTK uses too) CD47
https://med.stanford.edu/news/all-news/2017/11/second-dont-eat-me-signal-found-on-cancer-cells.html

https://www.gilead.com/news/news-details/2020/gilead-to-acquire-forty-seven-for-49-billion
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
HAVE NO CLUE WHAT THAT MEANS
👍️0
PonkenPlonken PonkenPlonken 1 month ago
I used to love this - always love me some dont eat me
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
STTK LOW VOLUME MOVE....SO DILUTION OFF THE TABLE
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
STTK COMING OFF BOTTOM
👍️0
glenn1919 glenn1919 6 months ago
STTK............................https://stockcharts.com/h-sc/ui?s=STTK&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 7 months ago
STTK under $4
👍️0
PonkenPlonken PonkenPlonken 10 months ago
absolutely revolutionary data in HR MDS... compare to SOC!!! HMAs show a ORR 30%, CR 10-20%
(also beats venetoclax + HMA in TP53m AML)

Observed 79% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete response (CR)/marrow complete response (mCR) rate of 64% –

– Observed 27% initial CR/complete response with incomplete hematologic recovery (CRi) in frontline TP53m AML patients, and 5/11 evaluable patients achieved stable disease with decreasing blast counts and peripheral blood count improvement, these patients continue on treatment
👍️0
Monksdream Monksdream 11 months ago
STTK new 52 week high
👍️0
Monksdream Monksdream 1 year ago
STTK new 52 week high
👍️0
Monksdream Monksdream 1 year ago
STTK new 52 week low
👍️0
tbonaces80 tbonaces80 1 year ago
Takeda gonna tender on next trial fast track
👍️0
tbonaces80 tbonaces80 1 year ago
load it-going to 10+
👍️0
subslover subslover 1 year ago
No fooling? So you say a 1.75% profit for a two-hour trade is a bad trade?
👍️0
tbonaces80 tbonaces80 1 year ago
Bad trade
👍️0
subslover subslover 1 year ago
Ok. I got out of this POS this morning at $5.00, got lucky is all
👍️0
TheFinalCD TheFinalCD 1 year ago
@ 4.29 I was just looking for a move under $4 and it did

small gain, but I didnt know how many borrows I could get if it went against me

sometimes I go short, and get upside down and cant average up, because broker all of a sudden has NO available shares to short= your stuck

so thats why I dont short much
👍️0
subslover subslover 1 year ago
What price did you short?tia
👍️0
TheFinalCD TheFinalCD 1 year ago
I shorted it... Its just Phase 1

AI bot hyper extended the POP

I used to chase these Pase 1 rallys, lost lots of money doing so

some of my biggest losses ever

Phase 1 Gap & Traps
👍️0
subslover subslover 1 year ago
Did you see this open? $7.28! then immediately dropped down to $2.50 omg. I'm in at $3.00 just hoping for the best. Worth a shot
👍️0
TheFinalCD TheFinalCD 1 year ago
$STTK KEEP THIS ON WATCH! pic.twitter.com/6owPN2LcXn— Tiger Line Trading (@TigerLineTrades) December 13, 2023
👍️0
subslover subslover 1 year ago
$TSOI's new Introducing the ALScell™, also known as the JadiCell™ – Now, these ALScells are not your run-of-the-mill mesenchymal stem cells; they're basically the overachievers of the cellular world. These ALScells have it all – enhanced growth factor production, like they've been hitting the gym and drinking protein shakes on a regular basis. They can secrete exosomes , outshining their stem cell peers who are still trying to figure out how to tie their cellular shoelaces.

But wait, there's more! These ALScells are not just content with being academically gifted; they've got some serious street smarts too. Superior angiogenic and neurogenic abilities mean they're like the cool kids who not only excel in science class but also throw legendary parties in the cellular neighborhood.

And guess what? Exosomes are not just a fancy word; they're the VIP pass to the cure of many cancers. It's like the ALScells are hosting the party, and exosomes are the invitations that cancer cells can't resist.

So, say hello to the ALScell™ – the cellular superhero ready to save the day, one enhanced growth factor at a time, and unlocking cures like a boss!
Bullish
BULLISH
👍️0
Awl416 Awl416 1 year ago
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Pati
👍️0
Monksdream Monksdream 1 year ago
STTK under $2
👍️0